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Purpose: To describe the phenotype of a family with an autosomal dominant macular dystrophy and identify the
chromosomal location of the gene that causes this phenotype.
Methods:  Twelve members of a  three-generation  family  underwent  routine  clinical  examination,  including  fundus
photography. Four of the patients underwent extended examination with Goldmann perimetry, full-field electroretinogram,
dark  adaptation,  and  color  vision  testing,  and  two  patients  underwent  optical  coherence  tomography  and  fundus
autofluorescence examination. DNA samples were obtained from 12 family members and 3 spouses and genotyped at the
known North Carolina Macular Dystrophy (NCMD) locus on chromosome 6q (MCDR1: OMIM 136550) using short
tandem repeat polymorphisms. DNA samples were subsequently examined with a genome-wide scan of single nucleotide
polymorphisms and the genotypes that were produced were studied with linkage and haplotype analyses.
Results: The 10 affected family members had clinical findings of macular lesions that are typical for NCMD. The small
drusen-like yellowish lesions of mild NCMD were hyperautofluorescent. Hyperpigmented foveal lesions were surrounded
by a zone of confluent hyperautofluorescence. Linkage analysis of short tandem repeat polymorphism genetic markers
exclude the NCMD locus on chromosome 6. However, analysis of single nucleotide polymorphism genotypes from a
genome-wide scan showed that NCMD in our pedigree is linked to a region on chromosome 5p that overlaps the previously
mapped macular dystrophy (MCDR3) locus with a maximum log of the odds (LOD) score of 2.69 at a recombination
fraction of 0.00 (markers D5S406, D5S1987, and D5S2505).
Discussion: We report the first pedigree with NCMD from Scandinavia, and the first confirmation that a gene for this
condition is located on chromosome 5p13-p15. The bright elements or lesions typical of NCMD differed from drusen in
that no sign of accumulation of material between the retinal pigment epithelium and Bruch’s membrane was seen. While
the present study has found indications that the elements are located in the outermost layers of the retina, their precise
location remains to be identified directly.
North  Carolina  macular  dystrophy  (NCMD)  is  an
autosomal  dominant  dystrophy  that  was  first  reported  as
hereditary macular degeneration and aminoaciduria by Lefler,
Wadworth,  and  Sidbury  [1].  Extensive  genealogical
investigations in this and other families from the United States
established a common ancestry to two Irish brothers who
settled in North Carolina in the 1830s [2], although at the time
the macular dystrophy was termed dominant foveal dystrophy
[3] or central areolar pigment epithelial dystrophy [4]. The
original North Carolina pedigree now consists of over 5,000
individuals (see review by Small [5]). Subsequently, families
with a similar spectrum of phenotypes have been reported
from Europe (the UK, Germany, and France) [6-8], Belize
[9], and Korea [10].
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The  main  characteristics  of  the  disease  consist  of:
symmetric, tiny drusen-like, yellowish deposits confined to
the foveal region with little or no impact on visual acuity
(Grade 1) [11]; confluent yellow flecks with intermediate
visual  impairment  (Grade  2);  or  colobomatous  macular
chorioretinal  atrophy  often  surrounded  by  pigment
aggregations and associated with moderate to severe visual
impairment (Grade 3). NCMD is generally nonprogressive
and  the  grading  does  not  reflect  successive  stages  of
progression [6]. Visual acuity is often astonishingly preserved
compared with the severe appearance of the retinal lesion.
Some individuals, however, develop subretinal neovascular
membranes, resulting in fibrosis and late vision loss [12].
Peripheral drusen formation in a linear configuration without
functional  significance  has  also  been  frequently  reported
[5-7,11]. Peripheral visual fields, full-field electroretinogram
(ERG),  and  electrooculogram  (EOG)  are  rarely  affected,
while multifocal ERG demonstrates the reduction of central
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2659cone responses. Additional functional studies have further
characterized the ocular phenotype of NCMD [6,13,14].
Linkage studies of NCMD pedigrees mapped a disease-
causing  gene  to  a  locus  (MCDR1,  OMIM  136550)  on
chromosome 6q16 [15,16], which was later narrowed to ~3
cM (1.8 mb) [5,17]. Despite comprehensive sequencing of all
11 known genes within this interval, the gene involved has not
yet been identified [18]. In the majority of pedigrees, NCMD
is linked to the inheritance of a disease-causing gene in the
chromosome  6q  MCDR1  locus,  and  a  common  ancestral
haplotype has been identified in most American families [5].
However, not all NCMD families are linked to the MCDR1
locus on chromosome 6q. Linkage analysis of a clinically well
documented family with a phenotype indistinguishable from
MCDR1  mapped  another  disease-causing  gene  to  a
chromosome  5p15  locus  (MCDR3,  OMIM  608850)  [19].
Furthermore, the gene that causes NCMD and progressive
sensorineural hearing loss in another large pedigree has been
mapped to chromosome 14q [20]. Lastly, an additional family
with  a  phenotype  similar  to  NCMD  has  been  linked  to
chromosome 6q14 adjacent to, but distinct from the MCDR1
locus, providing further evidence for genetic heterogeneity
[21]. Here, we report the clinical characterization and linkage
analysis of a Danish pedigree with features of NCMD.
METHODS
The study adhered to the Declaration of Helsinki and was
approved by the local ethics committee. All patients gave their
written consent after being informed about the purpose and
implications of the investigation.
Two patients from the same family were independently
referred to the National Eye Clinic for the Visually Impaired
(NEC) for diagnostic examination. The findings initiated a
supplementary examination of additional family members.
All patients underwent a standard examination, including a
review of their visual symptoms; assessment of refraction,
Snellen visual acuity, ocular alignment and motility; slit lamp
examination; ophthalmoscopy; and color fundus photography
of macular lesions. Some patients underwent supplementary
examination with Goldmann perimetry (object size IV4e and
I4e);  color  vision  screening  (Ishihara’s  38
pseudoisochromatic plates and Lanthony tritan plates); and
full-field  ERG  (ffERG;  Nicolet  Biomedical  Instruments,
Madison,  WI),  according  to  the  recommendations  by  the
International  Society  for  Clinical  Electrophysiology  and
Vision [22]. In addition, two of the patients underwent fundus
autofluorescence  imaging  using  a  confocal  scanning  laser
ophthalmoscope  and  optical  coherence  tomography
instrument (Spectralis; Heidelberg Engineering, Heidelberg,
Germany).  Blood  samples  were  obtained  from  family
members  and  DNA  was  prepared  from  the  blood  using
standard methods.
Pedigree  members  were  first  genotyped  with  short
tandem  repeat  polymorphism  (STRP)  genetic  markers
flanking the MCDR1 locus. Genotyping with STRP genetic
markers was conducted using standard methods, as previously
described  [23].  Twelve  and  one  half  nanograms  of  each
patient's DNA was used as template in an 8.35 μl polymerase
chain reaction (PCR) containing 1.25 μ of X10 buffer (100-
mMol/l  TRIS-hydrochloride  [pH,  8.8];  500-mMol/l
potassium  chloride;  and  15-mMol/l  magnesium  chloride,
0.01%  wt/vol  gelatin);  200  μl  each  of  deoxycytidine
triphosphate, deoxyATP, deoxyguanosine triphosphate and
deoxythymidine triphosphate; 1 pmol of each primer; and
0.25-U  Taq  polymerase  (Perkin-Elmer  Cetus,  Norwalk,
Conn). Samples were incubated in a DNA thermocycler for
35 cycles under the following conditions: 94 °C for 30 s, 55 °C
for 30 s, and 72 °C for 30 s. After amplification, 5 μ of stop
solution  (95%  formamide,  10-mMol/l  sodium  hydroxide,
0.05%  bromophenol  blue,  and  0.05%  xylene  cyanol)  was
added  to  each  sample.  Amplification  products  were  then
denatured and electrophoresed on 6% polyacrylamide gels at
60W for approximately 3 h. Following electrophoresis, gels
were silver stained as previously described [24] and genotypes
were scored by inspection. Next, a genome-wide scan was
performed with Affymetrix microarrays (Sty1 array of the
GeneChip  Human  Mapping  500K  Array  Set;  Affymetrix,
Santa Clara, CA), which interrogate 238,304 single nucleotide
polymorphisms (SNPs). Sample processing and labeling were
performed using the manufacturer’s instructions. The arrays
were hybridized, washed, and scanned in the University of
Iowa DNA core facility. Array images were processed with
GeneChip DNA Analysis software (Affymetrix). Microarray
data  were  analyzed  and  multipoint  nonparametric  linkage
scores  were  calculated  using  the  EasyLinkage  software
package [25]. Pairwise linkage analysis using STRP markers
was performed with the MLINK and LODSCORE programs,
as  implemented  in  the  FASTLINK  (v2.3)  version  of  the
LINKAGE software package [26-28]. Penetrance and disease
gene frequency were set to 99% and 0.01% respectively. For
each STRP marker, the allele frequencies were assumed to be
equal. True allele frequencies could not be reliably estimated
from the small number of spouses in the pedigree. To show
that the assumption of the equal allele frequencies would not
significantly affect our linkage results, we recalculated the log
of the odds (LOD) scores using allele frequencies for the
“affected” allele of the most tightly linked marker (D5S1987)
ranging from 0.01 to 0.5. The Zmax for D51987 was 2.69 when
the “affected” allele frequency was arbitrarily set to 50%,
suggesting that linkage is present despite assumptions about
allele frequencies.
RESULTS
Clinical  examinations:  Members  of  a  three-generation
pedigree (Figure 1) received complete eye examinations and
10 members were found to be clinically affected with NCMD.
Affected members of the family exhibited typical features of
NCMD, including characteristic macular lesions (Figure 2),
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2660relatively good visual acuity, and normal visual fields. The
clinical findings are summarized in Table 1.
Case reports: The proband, a 13-year-old school girl (Figure
1, III-3), was referred to NEC for diagnostic examinations due
to a macular disorder. Her only visual complaint was moderate
photophobia.  There  was  no  known  family  history  of  eye
disease. The examination showed a best corrected Snellen
visual acuity of 0.66 OD and 1.33 OS, hyperopia, and normal
color  discrimination.  Kinetic  visual  fields  (Goldmann
perimetry with I4e and IV4e targets) were slightly constricted
and  automated  perimetry  (Octopus  101)  showed  bilateral
defects in the lower right quadrant. Ophthalmoscopy revealed
slightly oval-shaped bilateral macular lesions consisting of
fine,  densely  packed,  grainy  depigmentations  resembling
small laminar drusen (Figure 2G,H). Scotopic and photopic
ffERG showed normal waveforms with normal amplitudes
and implicit times. At a follow-up examination two years later,
the findings were unchanged. At this time, examination of the
proband’s two elder sisters (III-1 and III-2), and a younger
brother  (III-4)  who  did  not  have  any  visual  complaints,
revealed the same macular lesions.
The proband’s paternal uncle (Figure 1, II-6) had a history
of subnormal vision that was detected at seven years of age
with screening tests at school, at which time “toxoplasmosis-
like” macular scars were noted in both eyes. At 33 years of
age, he was examined at NEC. He had no visual complaints
and a best corrected Snellen visual acuity of 0.5 OD and 0.4
OS. However, with questioning, he reported difficulties with
words  disappearing  during  reading.  His  color  vision  was
essentially normal (two errors were made on Ishihara plates
and  testing  with  Lanthony  tritan  plates  was  normal).
Goldmann  perimetry  showed  normal  outer  boundaries.
Figure 1. Pedigree of a Danish family
with  a  North  Carolina  macular
dystrophy-like  phenotype.  Individuals
found  to  be  clinically  affected  with
North  Carolina  macular  dystrophy
(NCMD)  are  represented  by  black
symbols, while unaffected individuals
are depicted with open symbols. Family
members with unknown affection status
and family members that did not meet
full criteria for a clinical diagnosis of
NCMD are indicated with gray symbols.
Individuals that are deceased are marked
with  a  slash.  Genotypes  from  seven
genetic  markers  on  the  long  arm  of
chromosome 5 are shown with the most
telomeric  markers  at  the  top.  The
genotypes detected for each marker are
shown beneath each subject’s pedigree
symbol to the right of the marker name.
The linked allele of each marker is on
the  left  and  boxed.  If  analysis  of  the
genotypes  revealed  a  meiotic
recombination,  the  box  around  the
recombinant allele is shaded black; if no
recombination was detected, the box has
been left unshaded. If the presence of a
recombination could not be determined,
the box is shaded gray. Genotypes that
could not be determined are indicated
with a dash, while those genotypes that
were  inferred  are  indicated  with  an
asterisk. The positions of the markers on
chromosome 5 are shown based on the
GRCh37/hg19  build  of  the  human
genome.
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2661Figure 2. Selected color fundus pictures of the North Carolina macular dystrophy pedigree. Right (left column) and left (right column) macular
regions are shown for four affected individuals: A-B, patient II-1; C-D, patient II-6; E-F, patient III-2; G-H, patient III-3. The macular lesions
A-B and E-H are grade 1, while the lesions in C-D are grade 3.
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2663Ophthalmoscopy  showed  small  round  heavily  pigmented
foveal scars surrounded by small drusen-like changes (Figure
2C,D).  The  appearance  of  the  same  macular  lesions  in
multiple  family  members  with  an  autosomal  dominant
inheritance pattern led to the diagnosis of NCMD.
The proband (III-3) and her paternal uncle (II-6) were
also examined with fundus autofluorescence imaging using
confocal  scanning  laser  ophthalmoscopy  and  optical
coherence tomography (OCT, Figure 3 and Figure 4). The
bright NCMD elements showed higher autofluorescence than
the background (Figure 4A). Semiconfluent dark areas of
lower autofluorescence were seen only in the central region
of the fovea (Figure 4A). The central hyperpigmented lesions
in the uncle were nonfluorescent, whereas the surrounding rim
of  bright  amorphous  subretinal  material  was
hyperfluorescent. Infrared images recorded at 790 nm (not
shown) showed the same element pattern as in red-free and
488 nm illumination, showing that element hyperreflectivity
extends toward the range of the OCT light source, which is
centered at 870 nm. On OCT, no definite hyperreflectivity
could be seen in the neurosensory retina (Figure 4A), whereas
irregularly distributed thickening of the photoreceptor outer
segment/retinal pigment epithelium (RPE) complex was seen
on multiple sections (Figure 4A,B). There were no signs of
accumulation of abnormal material between the base of the
RPE and Bruch’s membrane, where the drusen of age-related
macular degeneration are found. Stereoscopic montages of
red-free fundus images showed the bright elements posterior
to and at some distance from the retinal blood vessels (Figure
4C).
Genetic studies: DNA samples from affected family members
were studied with linkage analysis using a stepwise approach.
Linkage  to  the  previously  reported  chromosome  6q  locus
(MCDR1) was ruled out using a panel of STRP markers (data
not  shown).  Next,  a  genome-wide  scan  for  linkage  was
conducted using microarrays of SNP genetic markers on 9 of
the  10  affected  family  members.  Analysis  of  the  SNP
genotypes  identified  a  region  of  chromosome  5p  with  a
maximum nonparametric linkage score of 9.88 (p=0.0001).
The  affected  family  members  shared  an  allele  of  1081
consecutive SNPs that span 13.96 Mbp between the telomere
and  rs13154455.  The  linkage  to  5p  was  confirmed  by
genotyping all 10 affected members of the pedigree with seven
STRP markers that span the region (Figure 1). The maximum
two-point  parametric  LOD  score  of  2.69  (theta=0)  was
obtained with markers D5S406, D5S1987, and D5S2505.
The linked region for our pedigree partially overlaps with
the previously described NCMD locus, MCDR3 [19], and
combining  these  data  produces  a  critical  region  that  is
narrowed from 20.0 Mbp to 12.75 Mbp. This critical region
contains 55 known candidate genes, of which 30 are expressed
in  human  retina  and/or  RPE  (Table  2),  as  determined  by
studies with expression microarrays (data not shown).
DISCUSSION
The NCMD phenotype is characterized by diverse macular
lesions:  tiny,  drusen-like  material  in  the  macular  region,
foveal pigment epithelial atrophy, or bilateral coloboma-like
scars  with  hyperpigmentations.  The  lesions  are  either
congenital or appear in early infancy, and the visual acuity in
the best eye is often astonishingly good compared with the
extent of the macular affection. Among our patients, only one
(Figure 1, II-6; Figure 2C,D) had grade 3 lesions, while the
remaining nine appeared to have grade 1 lesions. None of the
affected family members had any visual complaints and their
macular  lesions  were  incidentally  discovered  with  the
Figure 3. Color (left) and autofluorescence (right) fundus photographs from the right eye of patient II-6, recorded at the age of 35 years.
Fluorescence was absent in a hyperpigmented central zone of outer retinal atrophy, whereas an irregular gray to white surrounding zone
showed confluent hyperautofluorescence. The general level of fundus autofluorescence outside the macula appeared to be normal.
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2664Figure 4. Fundus, autofluorescence, and optical coherence tomography (OCT) images of patients with North Carolina Macular Dystrophy
(NCMD). A: Fundus images from the right eye of patient III-3, recorded at the age of 19 years. Red-free fundus photographs (upper left) show
the dense pattern of approximately 1,500 small semiconfluent yellowish drusen-like elements of 12–25 µm in diameter distributed relatively
evenly within one disk diameter of the foveal center, except for a relative sparing of the most central part of the fovea. Autofluorescence
fundus photography (upper middle) shows marked hyperfluorescence of the bright drusen-like elements. Some of the smaller elements are
likely below the resolution of the autofluorescence imaging system. In and around the foveal center, small, irregular dark patches are seen,
which may be attributable to atrophy or to areas of normal fundus that are circumscribed by diffusely hyperfluorescent areas. The diffuse
fundus autofluorescence outside the macula does not appear to be elevated compared to healthy subjects of the patient’s age. Color fundus
photography (upper right) demonstrates the yellow color of the drusen-like elements being enhanced centrally, presumably by the xanthophyll
in Henle’s layer. Horizontal transfoveal optical coherence tomography (OCT, below) shows a normal anatomy of the inner retina, including
a normal foveal depression. The photoreceptor-retinal pigment epithelium (RPE) complex appears normal near the optic disk, where all three
hyperreflective (dark) and two intervening hyporeflective bands are visible. In the fovea, this pattern is interspersed by localized thickening
that involves both the inner and the outer layers of the complex. There are no definite signs of serous detachment of the RPE from Bruch’s
membrane, which gives the impression that the basal layers of the photoreceptor outer segment/RPE complex are thickened. Right under the
center of the foveola, the inner layers of this complex appear to be locally thickened. B: Selected OCTs from patient III-3, recorded at the age
of 19 years. Transfoveal (top and bottom) and parafoveal (middle) OCTs from the right eye (top and middle) and the left eye (bottom). The
foci of localized thickening of the photoreceptor outer segment/RPE complex (up arrows) were sufficiently hyperreflective to indicate that
the outer layers of the complex were thickened or that very small drusen had formed between the RPE and Bruch’s membrane. Serous
detachment of the RPE from Bruch’s membrane was not seen. Localized thickening of the inner layers of the complex was seen under the
center of the fovea (down arrow). C: Stereoscopic fundus photographs from patient III-3, recorded at the age of 19 years. The stereoscopic
effect is seen by converging on a point half way between the observer and the figure, so that the two images fuse to a third image in the middle
with stereoscopic depth.
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2665exception of two family members, who failed routine school
vision  testing.  The  appearance  of  characteristic  macular
lesions coupled with the autosomal dominant transmission,
normal color vision, and normal ffERG, strongly support a
diagnosis of NCMD.
While  in  most  pedigrees  NCMD  is  linked  to  the
chromosome 6q locus MCDR1 [5], the macular disease in one
NCMD family has been mapped to a chromosome 5p locus,
MCDR3 [19]. Here we report a second family with NCMD
that is also linked to the MCDR3 locus on chromosome 5p. In
addition to confirming the presence of the MCDR3 locus,
linkage data from our pedigree allows the MCDR3 critical
region to be reduced to  a 12.75   Mbp interval that contains 55
genes, 25 of which are expressed in the retina.
Minor phenotypic differences between NCMD that maps
to  MCDR1  and  that  which  maps  to  MCDR3  have  been
reported. Color vision defects were detected in members of
the  original  MCDR3  pedigree,  while  pedigrees  linked  to
MCDR1 have normal color vision. Progression of disease has
been reported in a single member of the original MCDR3
pedigree, but its rare occurrence does not seem to differentiate
between pedigrees linked to the MCDR1 and MCDR3 loci
[5,19]. Overall, these differences are of minor significance
and might represent familial characteristics within a single
phenotype. No definite color vision defects and no evidence
of disease progression were detected in our pedigree, which
is linked to the MCDR3 locus.
The  pathogenesis  of  NCMD  is  poorly  understood.
Histopathological studies have provided some insight. Light
microscopy of the eyes from a 72-year-old woman with grade
2 NCMD showed complete loss of photoreceptor cells and the
underlying RPE, Bruch’s membrane attenuation, and marked
atrophy of the choriocapillaris [29,30]. The same anatomic
lesions have been demonstrated by in-vivo OCT techniques
[13,31]. Fundus hyperautofluorescence, as seen in the drusen-
like material in NCMD in patient III-3, is not necessarily
evidence of the presence of any specific biochemical entity,
but in several other retinal diseases it is attributed to the
fluorophore  A2E,  a  retinoid  dimer  that  accumulates  in
conditions  where  the  visual  cycle  is  impaired.  Notable
conditions where fundus hyperfluorescence is higher than
normal  include  Stargardt’s  disease  [32]  and  age-related
macular  degeneration  [33].  In  these  two  conditions,
hyperautofluorescence  is  caused  by  increased  fluorescent
content in the RPE. In retinitis pigmentosa, as in age-related
macular  degeneration,  higher  than  normal  fundus
autofluorescence can be seen on the border between areas of
degenerated  and  preserved  photoreceptors  [34].  While
increased fluorophore content is one possible explanation for
this  phenomenon,  the  optical  unmasking  of  a  normal
fluorophore content by loss of natural retinal pigments such
as melanin is also a theoretical possibility.
Structural elements of the retina that appear bright in
infrared fundus photographs should show up on infrared OCT,
but in the case of NCMD elements, the lateral resolution of
the instrument may be insufficient to resolve the individual
elements.  The  lack  of  abnormal  hyperreflectivity  in  the
neurosensory retina in the young patient we investigated by
spectral-domain OCT suggests that the bright elements could
be located in the RPE and that their presence could be masked
by  the  high  reflectivity  of  the  normal  RPE.  The  bumpy,
irregular contour of the RPE noted on several of the OCT
scans  also  suggests  that  the  photoreceptor  outer  segment/
RPE- complex is the primary target of disease in NCMD. This
would  be  compatible  with  the  eventual  development  of
geographic outer retinal atrophy in the later stages of the
disease.
Decaying tissue of the outer retina is often seen outside
the  rim  of  a  chorioretinal  scar  such  as  the  central
hyperpigmented  scar  in  patient  II-6.  Such  bright,
hyperautofluorescent,  amorphous  material  may  be  a
nonspecific product of cell death.
In this report, we present a second NCMD family linked
to chromosome 5p that confirms the previous discovery of the
MCDR3 locus. Combining the linkage studies of our family
and the original MCDR3 produced a new critical region of
12.75 Mbp that contains a gene that causes NCMD. These
results  represent  important  steps  toward  the  discovery  of
genes that are capable of causing NCMD, which will provide
novel insights into the pathogenesis of this condition.
TABLE 2. GENES WITHIN THE LINKED REGION ON CHROMOSOME 5 THAT ARE EXPRESSED IN HUMAN RETINA AND/OR HUMAN RPE.
Human retina Human RPE Human Retina and RPE
ANKRD33B FAM105A ADCY2 CTNND2 LPCAT1 NSUN2
MARCH11 FAM105B ANKH DAP MARCH6 PAPD7
FAM173B CCT5 FAM134B MED10 SEMA5A
IRX2 CLPTM1L FASTKD3 MRPL36 TRI0
MTRR CMBL FBXL7 MYO10 UBE2QL1
KIAA0947 NDUFS6 ZNF622
           Expression was determined using Affymetrix U133 microarray platform using MAS 5.0 algorithm (data not shown).
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